Researchers identified a mutation in the WNT9B gene linked to significantly higher prostate cancer risk. Studies across multiple populations confirmed this finding, marking it as a major genetic risk factor alongside other established high-risk genes.
The discovery underscores (once more!) the importance of genetic screening for informed treatment and family risk assessment!
Six big things in metastatic prostate cancer
Glowing dye helps surgeons eradicate prostate cancer 
New prostate cancer diagnosis @ 52
Possible Prostate cancer
